Cough syrup contaminated with DEG has caused ARI and the death of many children in The Gambia.

Published Date: 06 Mar 2023

USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...

Read Full News

Latest News

IgA Nephropathy: From Clinical Suspicion to Definitive Diagnosis

IgA Nephropathy: From Clinical Suspicion to Definitive Diagnosis

Recognizing the Manifestations and Multidimensional Impacts of Sjögren's Disease

Recognizing the Manifestations and Multidimensional Impacts of Sjögren's Disease

Exploring Underlying Pathogenesis in Sjögren's Disease and a Rapidly Expanding Therapeutic Landscape

Exploring Underlying Pathogenesis in Sjögren's Disease and a Rapidly Expanding Therapeutic Landscape

New and Emerging Therapies in IgA Nephropathy: Latest Data and Clinical Implications

New and Emerging Therapies in IgA Nephropathy: Latest Data and Clinical Implications

Navigating New Guidelines in IgA Nephropathy

Navigating New Guidelines in IgA Nephropathy

Advances in Post-Kidney Transplant Immunosuppression: Applying the Latest CNI-Sparing Strategies to Optimize Long-Term Outcomes

Advances in Post-Kidney Transplant Immunosuppression: Applying the Latest CNI-Sparing Strategies to Optimize Long-Term Outcomes

Todays Updates

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.

FDA Approves Rusfertide for Polycythemia Vera

Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.

Todays Updates

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.

FDA Approves Rusfertide for Polycythemia Vera

Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.

Latest News

IgA Nephropathy: From Clinical Suspicion to Definitive Diagnosis

Recognizing the Manifestations and Multidimensional Impacts of Sjögren's Disease

Exploring Underlying Pathogenesis in Sjögren's Disease and a Rapidly Expanding Therapeutic Landscape

New and Emerging Therapies in IgA Nephropathy: Latest Data and Clinical Implications

Navigating New Guidelines in IgA Nephropathy

Advances in Post-Kidney Transplant Immunosuppression: Applying the Latest CNI-Sparing Strategies to Optimize Long-Term Outcomes

News All Time

First-in-Class Drug Approved for IgA Nephropathy

It has not been established whether atacicept slows kidney function decline long-term, however

Ushering in a New Era of IgAN Care: Targeted Therapies and Evolving Guidelines

Ushering in a New Era of IgAN Care: Targeted Therapies and Evolving Guidelines

Navigating New Guidelines in IgA Nephropathy

Navigating New Guidelines in IgA Nephropathy

FDA Greenlights Novel Hypertension Pill for Tough-to-Treat Patients

Aldosterone synthase inhibitor baxdrostat indicated as add-on to other antihypertensives

CAR T-Cell Therapy Enabled Kidney Transplant in Highly Sensitized Patients

Strategy offers hope for hard-to-match patients

Trial Dims Prospects for Rivaroxaban's Cardiovascular Protection in Advanced CKD

Trial finds risk, but no benefit, with blood thinner

When Should Our Patients With Diabetes Eat?

Meal timing may be an underused tool

Measured GFR in Line With eGFR for Predicting CKD Outcomes

Combining creatinine and cystitis C offered best accuracy for estimated calculations

B-Cell Depleter Nabs Phase III Win in Autoimmune Kidney Disease

Obinutuzumab tops immunosuppressant tacrolimus for membranous nephropathy remissions

Video: Police Tussle With Diabetes Experts at ADA Meeting

Researchers told they could no longer attend the annual scientific sessions

Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide

But its key advantage is in its weight reduction abilities

Finerenone Also Slows Kidney Decline in Diabetes-Free Patients

Benefits were consistent across glomerular disease subtypes, too

Monthly GLP-1 for Obesity Promising as More Manageable Alternative

Less frequent dosing could support better long-term adherence, says researcher

GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials

Phase III trials back CagriSema in different type 2 diabetes populations

APOL1 Gene and Focal Segmental Glomerulosclerosis

Genetic variants tied to increased risk are only found in those of African decent

Make the Diagnosis: Chest Pain, Dyspnea, Palpitations, and More: What’s Her Diagnosis?

A 45-year-old woman presented to the emergency department with complaints of chest pain, heart palpitations that developed earlier that day, and dyspnea that began 3 days prior and had progressed. Can you diagnose the patient?

Recommended News For You

X-ray and radar technology combined to reduce cancer screening risks

Exercise may help breast cancer survivors manage weight

Unified Neuro/Psych Residency Program: New Proposal.

Study suggests exercise could reduce breast cancer recurrence

Vapers May Be Less Likely to Undergo Lung Cancer Screening

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

Recommended Articles For You

Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes 

Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment  

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization 

Case-Based Learning on Adaptive Management of Oligometastatic Disease Across Treatment Phases 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

2.

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

3.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

4.

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

5.

The FDA Approves the New Frontline Aggressive ALL Regimen.

1.

Hematopoietic Stem Cell Exhaustion in Blood Disorders

2.

Lymphomatoid Papulosis: What You Need to Know

3.

The Growing Crisis of Aplastic Anemia: A Call for Action

4.

Importance of Early Detection in Hematology

5.

Clonal Hematopoiesis Dynamics and Future Hematologic Outcomes

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part X

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective

5.

Lung Cancer: Risk Factors and Prevention

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot